Justin Xiang
Fondatore presso Syno Partners LLC
Profilo
Justin Xiang is the founder and Chief Investment Officer at Syno Partners LLC, which he founded in 2015.
He is currently a Director at Seaport Diagnostics, Inc. Dr. Xiang was also a Director at LungLife AI, Inc.
Posizioni attive di Justin Xiang
| Società | Posizione | Inizio |
|---|---|---|
Seaport Diagnostics, Inc.
 Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | - |
Syno Partners LLC
 Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Fondatore | 01/01/2015 |
Precedenti posizioni note di Justin Xiang
| Società | Posizione | Fine |
|---|---|---|
| LUNGLIFE AI, INC. | Direttore/Membro del Consiglio | 01/07/2021 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| LUNGLIFE AI, INC. | Health Services |
| Aziende private | 2 |
|---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Finance |
- Borsa valori
- Insiders
- Justin Xiang
